Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP901253.RAZE6HNjBFQrd8h6OyllsunQlET1w7dB8U067Dok7Rmck130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP901253.RAZE6HNjBFQrd8h6OyllsunQlET1w7dB8U067Dok7Rmck130_assertion type Assertion NP901253.RAZE6HNjBFQrd8h6OyllsunQlET1w7dB8U067Dok7Rmck130_head.
- NP901253.RAZE6HNjBFQrd8h6OyllsunQlET1w7dB8U067Dok7Rmck130_assertion description "[Interestingly, reducing ChREBP(OG) levels via OGA overexpression decreased lipogenic protein content (ACC, FAS), prevented hepatic steatosis, and improved the lipidic profile of OGA-treated db/db mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP901253.RAZE6HNjBFQrd8h6OyllsunQlET1w7dB8U067Dok7Rmck130_provenance.
- NP901253.RAZE6HNjBFQrd8h6OyllsunQlET1w7dB8U067Dok7Rmck130_assertion evidence source_evidence_literature NP901253.RAZE6HNjBFQrd8h6OyllsunQlET1w7dB8U067Dok7Rmck130_provenance.
- NP901253.RAZE6HNjBFQrd8h6OyllsunQlET1w7dB8U067Dok7Rmck130_assertion SIO_000772 21471514 NP901253.RAZE6HNjBFQrd8h6OyllsunQlET1w7dB8U067Dok7Rmck130_provenance.
- NP901253.RAZE6HNjBFQrd8h6OyllsunQlET1w7dB8U067Dok7Rmck130_assertion wasDerivedFrom befree-20150227 NP901253.RAZE6HNjBFQrd8h6OyllsunQlET1w7dB8U067Dok7Rmck130_provenance.
- NP901253.RAZE6HNjBFQrd8h6OyllsunQlET1w7dB8U067Dok7Rmck130_assertion wasGeneratedBy ECO_0000203 NP901253.RAZE6HNjBFQrd8h6OyllsunQlET1w7dB8U067Dok7Rmck130_provenance.